Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1958 3
1964 1
1965 2
1967 2
1968 2
1969 2
1970 2
1971 6
1972 10
1973 6
1974 2
1975 7
1976 7
1977 8
1978 8
1979 10
1980 8
1981 9
1982 8
1983 10
1984 18
1985 17
1986 16
1987 8
1988 19
1989 21
1990 20
1991 22
1992 18
1993 16
1994 19
1995 26
1996 26
1997 39
1998 25
1999 40
2000 28
2001 33
2002 32
2003 40
2004 44
2005 57
2006 45
2007 50
2008 56
2009 62
2010 76
2011 64
2012 91
2013 89
2014 94
2015 77
2016 78
2017 71
2018 82
2019 90
2020 125
2021 135
2022 100
2023 78
2024 40

Text availability

Article attribute

Article type

Publication date

Search Results

2,001 results

Results by year

Filters applied: . Clear all
Page 1
Emerging Trends in Information-Seeking Behavior for Alpha-Gal Syndrome: Infodemiology Study Using Time Series and Content Analysis.
Romeiser JL, Jusko N, Williams AA. Romeiser JL, et al. J Med Internet Res. 2024 May 8;26:e49928. doi: 10.2196/49928. J Med Internet Res. 2024. PMID: 38717813 Free article.
BACKGROUND: Alpha-gal syndrome is an emerging allergy characterized by an immune reaction to the carbohydrate molecule alpha-gal found in red meat. ...Further research is needed to explore the evolving prevalence and impact of alpha-gal syndrome....
BACKGROUND: Alpha-gal syndrome is an emerging allergy characterized by an immune reaction to the carbohydrate molecule alpha-gal foun …
Experiences of patients living with HIV and AIDS on antiretroviral therapy in Accra, Ghana.
Agyeman-Yeboah J, Ricks EJ, Williams M, Jordan PJ. Agyeman-Yeboah J, et al. Curationis. 2024 Apr 16;47(1):e1-e7. doi: 10.4102/curationis.v47i1.2444. Curationis. 2024. PMID: 38708757 Free PMC article.
BACKGROUND: The human immunodeficiency virus and acquired immunodeficiency syndrome (HIV and AIDS) pandemic has greatly affected Africa, particularly Ghana. ...
BACKGROUND: The human immunodeficiency virus and acquired immunodeficiency syndrome (HIV and AIDS) pandemic has greatly affected Afri …
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.
Aygun B, Lane A, Smart LR, Santos B, Tshilolo L, Williams TN, Olupot-Olupot P, Stuber SE, Tomlinson G, Latham T, Ware RE; REACH Investigators. Aygun B, et al. Lancet Haematol. 2024 Apr 30:S2352-3026(24)00078-4. doi: 10.1016/S2352-3026(24)00078-4. Online ahead of print. Lancet Haematol. 2024. PMID: 38701812
BACKGROUND: Realizing Effectiveness Across Continents with Hydroxyurea (REACH) is an open-label non-randomised trial of hydroxyurea (hydroxycarbamide) in children with sickle cell anaemia in sub-Saharan Africa. ...In this paper we report results from extended hydrox …
BACKGROUND: Realizing Effectiveness Across Continents with Hydroxyurea (REACH) is an open-label non-randomised trial of hydrox …
Investigation of smoking on the antiplatelet response to clopidogrel: Unravelling the smoker's paradox.
Plakogiannis FA, Weidmann J, Fraser B, Kwong J, Asi D, Kumar P, Baldock M, Naamo J, Baluja R, Catanzariti R, Yeung S, Pont L, Williams K, De Rubis G, Dua K, Bukhari NI. Plakogiannis FA, et al. Pathol Res Pract. 2024 May;257:155290. doi: 10.1016/j.prp.2024.155290. Epub 2024 Apr 10. Pathol Res Pract. 2024. PMID: 38640781 Free article. Review.
Moreover, an investigation of the effects of genetic variability on the smoker's paradox was undertaken from both clinical and molecular perspectives, delving into the effects of ethnicity and genetic polymorphisms. ...
Moreover, an investigation of the effects of genetic variability on the smoker's paradox was undertaken from both clinical and molecu …
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial.
Patel VC, McPhail MJ, Uddin R, Jafari H, Lawrence V, Le Boutillier C, Shearer J, Yaziji N, Cape A, Ahmed H, Ward C, Walsh P, Besly K, Zamalloa A, Kelly J; BOPPP study group; Carter B. Patel VC, et al. Trials. 2024 Apr 16;25(1):265. doi: 10.1186/s13063-024-08063-3. Trials. 2024. PMID: 38627804 Free PMC article.
It remains uncertain whether administering a non-selective beta-blocker (NSBB), specifically carvedilol, at an earlier stage, i.e. when oesophageal varices are small, can prevent VH and reduce all-cause decompensation (ACD). METHODS/DESIGN: The BOPPP trial is a pragmatic, …
It remains uncertain whether administering a non-selective beta-blocker (NSBB), specifically carvedilol, at an earlier stage, i.e. when oeso …
Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal: A Post Hoc Subgroup Analysis of the ESC-NOW Randomized Clinical Trial.
Devlin LA, Hu Z, Merhar SL, Ounpraseuth ST, Simon AE, Lee JY, Das A, Crawford MM, Greenberg RG, Smith PB, Higgins RD, Walsh MC, Rice W, Paul DA, Maxwell JR, Fung CM, Wright T, Ross J, McAllister JM, Crowley M, Shaikh SK, Christ L, Brown J, Riccio J, Wong Ramsey K, Braswell EF, Tucker L, McAlmon K, Dummula K, Weiner J, White JR, Newman S, Snowden JN, Young LW; Eunice Kennedy Shriver NICHD Neonatal Research Network and NIH Environmental Influences on Child Health Outcomes (ECHO) Program Institutional Development Award States Pediatric Clinical Trials Network. Devlin LA, et al. JAMA Pediatr. 2024 Apr 15:e240544. doi: 10.1001/jamapediatrics.2024.0544. Online ahead of print. JAMA Pediatr. 2024. PMID: 38619854 Free PMC article.
DESIGN, SETTING, AND PARTICIPANTS: This post hoc subgroup analysis involved infants pharmacologically treated in ESC-NOW, a stepped-wedge cluster randomized clinical trial conducted at 26 US hospitals. Hospitals maintained pretrial practices for pharmacologic …
DESIGN, SETTING, AND PARTICIPANTS: This post hoc subgroup analysis involved infants pharmacologically treated in ESC-NOW, a stepped-wedge cl …
Necroptosis blockade prevents lung injury in severe influenza.
Gautam A, Boyd DF, Nikhar S, Zhang T, Siokas I, Van de Velde LA, Gaevert J, Meliopoulos V, Thapa B, Rodriguez DA, Cai KQ, Yin C, Schnepf D, Beer J, DeAntoneo C, Williams RM, Shubina M, Livingston B, Zhang D, Andrake MD, Lee S, Boda R, Duddupudi AL, Crawford JC, Vogel P, Loch C, Schwemmle M, Fritz LC, Schultz-Cherry S, Green DR, Cuny GD, Thomas PG, Degterev A, Balachandran S. Gautam A, et al. Nature. 2024 Apr;628(8009):835-843. doi: 10.1038/s41586-024-07265-8. Epub 2024 Apr 10. Nature. 2024. PMID: 38600381
Severe influenza A virus (IAV) infections can result in hyper-inflammation, lung injury and acute respiratory distress syndrome(1-5) (ARDS), for which there are no effective pharmacological therapies. ...UH15-38 displayed robust therapeutic efficacy even when administered …
Severe influenza A virus (IAV) infections can result in hyper-inflammation, lung injury and acute respiratory distress syndrome(1-5) …
Immediate Versus Staged Complete Revascularization in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Cheema HA, Bhanushali K, Sohail A, Fatima A, Hermis AH, Titus A, Ahmad A, Majmundar V, Rehman WU, Sulaiman S, Lakhter V, Baron SJ, Dani SS. Cheema HA, et al. Am J Cardiol. 2024 Apr 4;220:77-83. doi: 10.1016/j.amjcard.2024.03.037. Online ahead of print. Am J Cardiol. 2024. PMID: 38582316
A strategy of complete revascularization (CR) is recommended in patients with acute coronary syndrome (ACS) and multivessel disease (MVD). However, the optimal timing of CR remains equivocal. We searched MEDLINE, Embase, the Cochrane Library, and ClinicalTrials.gov for …
A strategy of complete revascularization (CR) is recommended in patients with acute coronary syndrome (ACS) and multivessel disease ( …
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
D'Angelo SP, Araujo DM, Abdul Razak AR, Agulnik M, Attia S, Blay JY, Carrasco Garcia I, Charlson JA, Choy E, Demetri GD, Druta M, Forcade E, Ganjoo KN, Glod J, Keedy VL, Le Cesne A, Liebner DA, Moreno V, Pollack SM, Schuetze SM, Schwartz GK, Strauss SJ, Tap WD, Thistlethwaite F, Valverde Morales CM, Wagner MJ, Wilky BA, McAlpine C, Hudson L, Navenot JM, Wang T, Bai J, Rafail S, Wang R, Sun A, Fernandes L, Van Winkle E, Elefant E, Lunt C, Norry E, Williams D, Biswas S, Van Tine BA. D'Angelo SP, et al. Lancet. 2024 Apr 13;403(10435):1460-1471. doi: 10.1016/S0140-6736(24)00319-2. Epub 2024 Mar 27. Lancet. 2024. PMID: 38554725 Clinical Trial.
METHODS: SPEARHEAD-1 was an open-label, non-randomised, phase 2 trial done across 23 sites in Canada, the USA, and Europe. The trial included three cohorts, of which the main investigational cohort (cohort 1) is reported here. ...
METHODS: SPEARHEAD-1 was an open-label, non-randomised, phase 2 trial done across 23 sites in Canada, the USA, and Europe. The …
Flecainide causing elevated capture thresholds on pacemaker implantation.
Leow KC, Lim WY, Lee A, Rahman M, Tan R. Leow KC, et al. BMJ Case Rep. 2024 Mar 21;17(3):e259098. doi: 10.1136/bcr-2023-259098. BMJ Case Rep. 2024. PMID: 38514158
Flecainide is a Vaughan Williams class 1c antiarrhythmic used to treat supraventricular and ventricular arrhythmias. ...We describe a report of a patient, in her early 80s, presenting with tachy-brady syndrome on a background of permanent atrial fibrillation. She wa …
Flecainide is a Vaughan Williams class 1c antiarrhythmic used to treat supraventricular and ventricular arrhythmias. ...We describe a …
2,001 results